Today: 1 April 2026
CrowdStrike Stock Gets Morgan Stanley Upgrade as Strong Outlook Blunts AI Fears

CrowdStrike Stock Gets Morgan Stanley Upgrade as Strong Outlook Blunts AI Fears

NEW YORK, March 10, 2026, 3:43 PM EDT.

CrowdStrike Holdings was little changed in afternoon trading on Tuesday after Morgan Stanley upgraded the cybersecurity company to overweight and raised its price target. The shares were at $434.25, up 12 cents from a previous close of $434.13, after a six-session winning streak through Monday. Yahoo Finance

The call matters because CrowdStrike has become a test of whether new AI tools will eat into parts of the cybersecurity market or push customers toward bigger software platforms. CrowdStrike, Zscaler and other cyber names sold off in late February after Anthropic launched Claude Code Security, though JPMorgan strategists later said investors had been pricing in a worst-case disruption scenario. Reuters

Barron’s, citing Morgan Stanley’s note, said the bank lifted its price target to $510 from $487. Excerpts published Tuesday said analysts Meta A. Marshall and Keith Weiss saw CrowdStrike as staying “in rarified air” among software companies still growing more than 20% at scale. Barron’s

CrowdStrike gave bulls fresh numbers on March 3. It forecast fiscal 2027 revenue of $5.87 billion to $5.93 billion, above analysts’ estimates, as fourth-quarter revenue rose 23% to $1.31 billion. “I think people are still digesting numbers. But in this environment, having a software stock trade close to flat post print seems like a good outcome,” Truist Securities analyst Junaid Siddiqui told Reuters. The company also said costs tied to the July 2024 Windows outage and related matters rose to $117.7 million in fiscal 2026, though they narrowed in the latest quarter. Reuters

In its earnings release, Chief Executive George Kurtz said fiscal 2026 would “go down in our history books as CrowdStrike’s best year yet” after the company reached $5.25 billion in annual recurring revenue, or subscription revenue normalized over a year. He also said AI adoption was making CrowdStrike “mission-critical infrastructure.” Securities and Exchange Commission

CrowdStrike is still fighting for security budgets against larger platform vendors such as Palo Alto Networks and cloud-security rival Zscaler. Palo Alto last month cut its annual adjusted profit forecast as deal costs rose, while Zscaler reported a wider quarterly loss in what Reuters described as a competitive market. Reuters

But the trade still has an obvious weak spot. Excerpts published by Investing.com said Morgan Stanley argued CrowdStrike’s premium valuation versus peers had to be backed by reaccelerating growth and free-cash-flow margins above 30%. That leaves little room for a stumble if customer spending softens or AI tools start to pressure pricing. Investing.com

CrowdStrike has also been widening its reach beyond endpoint protection, software that secures laptops and servers. Reuters reported in January that it agreed to buy identity-security startup SGNL for $740 million and browser security firm Seraphic Security for about $420 million, and a separate Reuters report on Monday said it had sued rival AiStrike in California federal court over alleged trademark infringement. Reuters

Stock Market Today

  • TSX Stocks Air Canada, BlackBerry, and More Defy Doubters with Strong Performance
    March 31, 2026, 8:49 PM EDT. A year later, several TSX stocks have disproven negative forecasts by posting stronger earnings and cash flows than expected. Air Canada (TSX:AC) showcased resilience amid operational challenges, reporting full-year 2025 revenues of $22.37 billion and net income of $644 million, while executing $850 million in share buybacks. BlackBerry (TSX:BB) continued its transformation from a legacy brand to a profitable software entity, with fiscal Q3 2026 net income of $13.7 million and raised revenue guidance to $531-$541 million. Despite valuations reflecting caution-Air Canada trades at 10 times earnings and BlackBerry at 97 times-both demonstrate improving fundamentals, delivered by stronger margins, healthier cash flows, and clearer strategic execution that might prompt market re-ratings.
AbbVie Obesity Drug ABBV-295 Hits Up to 9.8% Weight Loss in Early Trial
Previous Story

AbbVie Obesity Drug ABBV-295 Hits Up to 9.8% Weight Loss in Early Trial

Delta Air Lines Stock Falls as Fuel-Cost Surge Clouds 2026 Outlook
Next Story

Delta Air Lines Stock Falls as Fuel-Cost Surge Clouds 2026 Outlook

Go toTop